Appointment New Patient Appointment or 214-645-8300

MedBlog

Hans Hammers, M.D., Ph.D.

Cancer

New immunotherapy drug combination is a significant advancement in kidney cancer therapy

A new immunotherapy drug combination has been dubbed a significant advancement in kidney cancer treatment. The combination of ipilimumab and nivolumab can improve outcomes and quality of life. Learn more.

Cancer

The Team That's Doubling Cancer Survival Rates

Cancer

Immunotherapy for kidney cancer: Using the body as a weapon

Kidney cancer patients may see long-lasting tumor shrinkage with immunotherapy, which uses the immune system as a weapon to fight cancer. Learn more.